Brominated Flame Retardants in Antarctic Air in the Vicinity of Two All-Year Research Stations

Continuous atmospheric sampling was conducted between 2010–2015 at Casey station in Wilkes Land, Antarctica, and throughout 2013 at Troll Station in Dronning Maud Land, Antarctica. Sample extracts were analyzed for polybrominated diphenyl ethers (PBDEs), and the naturally converted brominated compound, 2,4,6-Tribromoanisole, to explore regional profiles. This represents the first report of seasonal resolution of PBDEs in the Antarctic atmosphere, and we describe conspicuous differences in the ambient atmospheric concentrations of brominated compounds observed between the two stations. Notably, levels of BDE-47 detected at Troll station were higher than those previously detected in the Antarctic or Southern Ocean region, with a maximum concentration of 7800 fg/m3. Elevated levels of penta-formulation PBDE congeners at Troll coincided with local building activities and subsided in the months following completion of activities. The latter provides important information for managers of National Antarctic Programs for preventing the release of persistent, bioaccumulative, and toxic substances in Antarctica.

Download Full-text

Women with high plasma levels of PBDE-47 are at increased risk of preterm birth

Journal of Perinatal Medicine ◽

10.1515/jpm-2020-0349 ◽

2020 ◽

Vol 0 (0) ◽

Author(s):

Morgan R. Peltier ◽

Michael J. Fassett ◽

Yuko Arita ◽

Vicki Y. Chiu ◽

Jiaxiao M. Shi ◽

...

Keyword(s):

Preterm Birth ◽

Los Angeles ◽

Polybrominated Diphenyl Ethers ◽

Flame Retardants ◽

Plasma Concentrations ◽

First Trimester ◽

High Plasma ◽

Thyroid Stimulating Hormone ◽

Spontaneous Preterm Birth ◽

Increased Risk

Abstract Objectives Nearly 100% of North American women have detectable levels of flame retardants such as polybrominated diphenyl ethers (PBDEs) in their plasma. These molecules have structural homology to thyroid hormones and may function as endocrine disruptors. Thyroid dysfunction has previously been associated with increased risk for preterm birth. Therefore, we conducted a multi-center, case-cohort study to evaluate if high plasma concentrations of a common PBDE congener in the first trimester increases the risk of preterm birth and its subtypes. Methods Pregnant women were recruited at the onset of initiation of prenatal care at Kaiser-Permanente Southern California (KPSC)-West Los Angeles and KPSC-San Diego medical centers. Plasma samples from women whose pregnancies ended preterm and random subset of those delivering at term were assayed for PBDE-47 and thyroid-stimulating hormone (TSH) by immunoassay. Quartile cutoffs were calculated for the patients at term and used to determine if women with exposures in the 4th quartile are at increased risk for preterm birth using logistic regression. Results We found that high concentrations of PBDE-47 in the first trimester significantly increased the odds of both indicated (adjusted odds ratio, adjOR=2.35, 95% confidence interval [CI]: 1.31, 4.21) and spontaneous (adjOR=1.76, 95% CI: 1.02, 3.03) preterm birth. Regardless of pregnancy outcome, TSH concentrations did not differ between women with high and low concentrations of PBDE-47. Conclusions These results suggest that high plasma concentrations of PBDE-47 in the first trimester, increases the risk of indicated and spontaneous preterm birth.

Download Full-text

Neurodevelopmental toxicity assessment of flame retardants using a human DNT in vitro testing battery

Cell Biology and Toxicology ◽

10.1007/s10565-021-09603-2 ◽

2021 ◽

Author(s):

Jördis Klose ◽

Melanie Pahl ◽

Kristina Bartmann ◽

Farina Bendt ◽

Jonathan Blum ◽

...

Keyword(s):

Human Cell ◽

Polybrominated Diphenyl Ethers ◽

Flame Retardants ◽

Real Life ◽

Toxicity Assessment ◽

Oligodendrocyte Differentiation ◽

Neurodevelopmental Toxicity ◽

Diphenyl Phosphate

AbstractDue to their neurodevelopmental toxicity, flame retardants (FRs) like polybrominated diphenyl ethers are banned from the market and replaced by alternative FRs, like organophosphorus FRs, that have mostly unknown toxicological profiles. To study their neurodevelopmental toxicity, we evaluated the hazard of several FRs including phased-out polybrominated FRs and organophosphorus FRs: 2,2′,4,4′-tetrabromodiphenylether (BDE-47), 2,2′,4,4′,5-pentabromodiphenylether (BDE-99), tetrabromobisphenol A, triphenyl phosphate, tris(2-butoxyethyl) phosphate and its metabolite bis-(2-butoxyethyl) phosphate, isodecyl diphenyl phosphate, triphenyl isopropylated phosphate, tricresyl phosphate, tris(1,3-dichloro-2-propyl) phosphate, tert-butylphenyl diphenyl phosphate, 2-ethylhexyl diphenyl phosphate, tris(1-chloroisopropyl) phosphate, and tris(2-chloroethyl) phosphate. Therefore, we used a human cell–based developmental neurotoxicity (DNT) in vitro battery covering a large variety of neurodevelopmental endpoints. Potency according to the respective most sensitive benchmark concentration (BMC) across the battery ranked from <1 μM (5 FRs), 1<10 μM (7 FRs) to the >10 μM range (3 FRs). Evaluation of the data with the ToxPi tool revealed a distinct ranking (a) than with the BMC and (b) compared to the ToxCast data, suggesting that DNT hazard of these FRs is not well predicted by ToxCast assays. Extrapolating the DNT in vitro battery BMCs to human FR exposure via breast milk suggests low risk for individual compounds. However, it raises a potential concern for real-life mixture exposure, especially when different compounds converge through diverse modes-of-action on common endpoints, like oligodendrocyte differentiation in this study. This case study using FRs suggests that human cell–based DNT in vitro battery is a promising approach for neurodevelopmental hazard assessment and compound prioritization in risk assessment. Graphical abstract

Download Full-text